Actuate Therapeutics, Inc. (NASDAQ:ACTU) Financings

Actuate Therapeutics, Inc.

Financings

RaiseDate
Public offering of common stock and warrants
Announced: about US$11M · US$0.71 a share · 1 warrant at US$0.45 for 60 months · Newbridge Securities Corporation
Dealers: Newbridge Securities Corporation (lead)
Use of proceeds: Working capital and general corporate purposes
Oct 27, 2026
Public offering of common stock
Closed: US$17.25M raised · US$7 a share · Lucid Capital Markets +1
Dealers: Lucid Capital Markets (lead), Titan Partners Group, a division of American Capital Partners
Use of proceeds: Working capital and general corporate purposes
Sep 11, 2025

Read by 6ix AI from the company's releases